Position in REGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$118,377,821
-$48,195,636 QoQ
Shares Held
189,848
-11.9% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#69
of 1,322 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swedbank AB holds $1,373,398,390 across 23 Biotechnology names. REGN ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
10,726,608 | $601,440,910 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
968,092 | $233,281,129 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
282,444 | $140,298,407 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
189,848 | $118,377,821 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,314,787 | $75,232,112 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $45,801,140 | |
| 7 | INCY |
Incyte Corp
|
371,387 | $42,100,430 | |
| 8 | 775,032 | $24,359,255 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $118,377,821 | 189,848 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $166,573,457 | 215,590 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $175,815,776 | 227,779 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $116,597,929 | 207,370 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $119,855,925 | 228,297 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $127,144,494 | 178,491 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $157,016,359 | 149,363 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $142,580,627 | 135,658 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $129,247,017 | 134,294 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $91,292,097 | 103,943 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $38,436,346 | 46,705 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $31,608,574 | 43,990 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $35,137,074 | 42,763 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $29,427,412 | 40,787 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $26,336,877 | 38,232 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $21,416,639 | 36,230 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $24,409,080 | 34,949 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $21,820,279 | 34,552 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $24,559,414 | 40,582 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $22,569,484 | 40,408 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $19,118,641 | 40,408 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||